- Fund Type: Open-End Fund
- Objective: Growth and Income
- Asset Class: Equity
- Geographic Focus: Global
CPB - Advisory One
+ Add to WatchlistESAD1EV:AV
11.22 EUR 0.05 0.44%As of 00:59:30 ET on 05/17/2013.
Snapshot for CPB - Advisory One (ESAD1EV)
| Year To Date: | - | 3-Month: | - | 3-Year: | - | 52-Week Range: | 9.82 - 11.27 |
|---|---|---|---|---|---|---|---|
| 1-Month: | - | 1-Year: | - | 5-Year: | - | Beta vs ATX: | 0.56 |
Fund Profile & Information for ESAD1EV
Advisory One is an open-end investment fund incorporated in Austria. The Fund's objective is income and growth. Advisory One invests globally in stocks.
| Inception Date: | 01-15-2008 | Telephone: | +43 (0) 50100-0 |
|---|---|---|---|
| Managers: | FRANZ WEBER | ||
| Web Site: | www.erste-am.at | ||
Fundamentals for ESAD1EV
| NAV | (on 2013-05-17) 11.22 |
|---|---|
| Assets (M) | (on 2013-05-17) 22.21 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for ESAD1EV
No dividends reported
Fees & Expenses for ESAD1EV
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 1.80 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | 2.10 |
Top Fund Holdings for ESAD1EV
Filing Date: 12/28/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| RAGB 3.8 10/20/13 | 2,500 | 2,593,209 | 9.947% |
| POLGB 5 ¼ 04/25/13 | 8,000 | 2,048,875 | 7.859% |
| VOSTOK 9 ⅞ 03/11/15 | 1,600 | 1,372,631 | 5.265% |
| IMMOFINANZ AG | 240,000 | 770,400 | 2.955% |
| Allianz SE | 4,500 | 476,325 | 1.827% |
| CPB - Tury Energie/Rohstoffe E | 50,000 | 463,000 | 1.776% |
| RenFin Ltd | 8,735 | 462,431 | 1.774% |
| CPB - Mozart One | 4,000 | 420,960 | 1.615% |
| Erste Sparinvest - Hidden Pear | 4,000 | 410,560 | 1.575% |
| Hong Kong Exchanges and Cleari | 30,000 | 385,781 | 1.480% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page